Efficacy and Safety of Mogamulizumab for Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis
Authors:
- Ayomide LawalALAyomide Lawal
- Amanda Ribeiro RangelARAmanda Ribeiro Rangel
- Advait RajaARAdvait Raja
- Maria Antônia Costa Cruz AkabaneMAMaria Antônia Costa Cruz Akabane
- Nathália Veloso LanaNLNathália Veloso Lana
- Falaknaz SaleemFSFalaknaz Saleem
- Ana Paula Pedroso JungesAJAna Paula Pedroso Junges
- Kelen Klein HeffelKHKelen Klein Heffel
- 1 May 2026
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 26 (7) , 436-446.e8
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World CohortClinical Lymphoma Myeloma and Leukemia, 2025
- Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort studyeClinicalMedicine, 2024
- Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in JapanHematological Oncology, 2024
- Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysisInternational Journal of Hematology, 2024
- Indolent Cutaneous T-Cell Lymphomas2021
- Overview of Cutaneous T-Cell LymphomasHematology/Oncology Clinics of North America, 2019
- Tumor Microenvironment in T-Cell Lymphomas2018
- Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory diseaseCancer Treatment Reviews, 2017
- Advanced-Stage Mycosis Fungoides and Sézary Syndrome: Survival and Response to TreatmentClinical Lymphoma Myeloma and Leukemia, 2015
- Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse modelCancer Immunology, Immunotherapy, 2008